Only two studies (25, 26) highlighted the potential of radiomics to predict TERT promoter mutation status in patients with GBM, providing evidence that radiomic features extracted from routine preoperative MRI images can be used as non-invasive biomarkers for TERT classification. This evidence concerns the gene TERT and glioblastoma.